The Venture Codex Logo

The Venture Codex

Overview

Disease-modifying therapies for rare genetic diseases.

Total Raised

$30 M

Rounds

1

Links

Verticals

Biotechnology
Health Care
Therapeutics

Investment History

  1. Series A

    Oct 2018

    $30M

Team

Daniel DiPietro

Co-Founder & Sr. Vice President

Laurie Tsuruda

Vice President, Pharmacology and Toxicology

Candice Henkel

Senior Clinical Trial Manager